Trastuzumab,Tucatinib
Seagen,Roche
[]
the #oncoalerttoptweet for day1 #gi23 tweet gives accelerated approval of tucatinib in combo w/trastuzumab for previously treated ras wt her2- met #colorectalcancer 1 st fda approved tx in her2 met #crc 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨